Hypertrophic cardiomyopathy is a global disease including China

International Journal of Cardiology

Volumn 127, Issue 1, 2008, Pages 1-4

  Cheng, Tsung O ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN HEAVY CHAIN BETA; TROPONIN T;

CARDIOVASCULAR DISEASE; CHINA; CHINESE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EDITORIAL; EPIDEMIC; EUROPE; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HEALTH SURVEY; HISTORY OF MEDICINE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL LITERATURE; MISSENSE MUTATION; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SUDDEN DEATH; UNITED STATES;

CARDIOMYOPATHY, HYPERTROPHIC; CHINA; FEMALE; HUMANS; MALE; WORLD HEALTH;

EID: 44149112247     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.165     Document Type: Editorial

References (34)

1. Liouville H. Retrecissement cardiaque sous aortique. Gaz Med Paris 24 (1869) 161
2. Hallopeau L. Retrecissement ventriculo-aortique. Gaz Med Paris 24 (1869) 683
3. Schmincke A. Ueber linksseitige muskulose conusstenosen. Dtsch Med Woehenschr 33 (1907) 2082
4. Acierno L.J. The history of cardiology (1994), The Parthenon Publishing Group, London 78
5. Brock R.C. Functional obstruction of the left ventricle. Guy Hosp Rep 106 (1957) 221-238
6. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20 (1958) 1-8
7. Maron B.J. Hypertrophic cardiomyopathy: an important global disease. Am J Med 116 (2004) 63-65
8. Zou Y., Song L., Wang Z., et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med 116 (2004) 14-18
9. Ho H.H., Lee K.L.F., Lau C.P., and Tse H.F. Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy. Am J Med 116 (2004) 19-23
10. Cheng T.O. Cardiology in People's Republic of China - Paul D. White lecture. In: Russek H. (Ed). New Horizons in Cardiovascular Practice (1975), University Park Press, Baltimore 1-27
11. Cheng T.O. Hypertrophic cardiomyopathy in China: three decades of progress. Int J Cardiol 100 (2005) 493-494
12. Shanghai First Medical University Zhong Shan Hospital, and Shanghai Institute of Cardiovascular Diseases. Clinical investigation of 74 cases of primary cardiomyopathy: II. Obstructive and restrictive primary cardiomyopathy. Chin J Intern Med 16 (1977) 340-346
13. Fang W.H., Guo H.S., Tao P., Wang S.H., from the Cardiovascular Institute, and Chinese Academy of Medical Sciences. Discussion about some questions on the diagnosis of hypertrophic cardiomyopathy. An analysis of 44 cases of angiographically confirmed cases. Chin J Intern Med 21 (1982) 596-599
14. Chinese Society of Cardiology. Editorial Board of Chinese Journal of Cardiology: a report of 3rd Chinese Conference on Myocarditis and Cardiomyopathy. Chin J Cardiol 35 (2007) 3-4
15. Chinese Society of Cardiology. Editorial Board of Chinese Journal of Cardiology, "Consensus on Diagnosis and Treatment of Cardiomyopathies" Chinese Expert Panel: recommendations on diagnosis and treatment of cardiomyopathies. Chin J Cardiol 35 (2007) 5-16
16. Xie M.X., Wang X.F., Cheng T.O., Lu Q., Yuan L., and Lou X. Real-time 3-dimensional echocardiography: a review of the development of the technology and its clinical application. Progr Cardiovasc Dis 48 (2005) 209-225
17. Cheng T.O. Clinical application of real-time three-dimensional echocardiography. J Cardiol 49 (2007) 213-214
18. Ho C.Y., and Seidman C.E. A contemporary approach to hypertrophic cardiomyopathy. Circulation 113 (2006) e858-e862
19. Spirito P., Seidman C.E., McKenna W.J., and Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
20. Song L., Zou Y., Wang J., et al. Mutations profile in Chinese patients with hypertrophic cardiomyopathy. Clin Chim Acta 351 (2005) 209-216
21. Liao Y.H. From etiological research to clinical diagnosis and therapeutic practice in cardiomyopathies. Chin J Cardiol 35 (2007) 1-2
22. Cheng T.O. Prevalence of hypertrophic cardiomyopathy in China. Chin Med J 117 (2004) 1600
23. Cheng T.O. Frequency of cardiac troponin I mutations in families with hypertrophic cardiomyopathy in China. J Am Coll Cardiol 46 (2005) 180-181
24. Wang S.X., Zou Y.B., Fu C.Y., Wang H., Wang J.Z., Song X.D., et al. Clinical features of dilated cardiomyopathy-like hypertrophic cardiomyopathy caused by 13261G>A mutation in cardiac myosin-binding protein C gene. Chin J Cardiol 35 (2007) 17-20
25. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346 (1995) 211-214
26. Maron B.J. Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy. Lancet 355 (2000) 425-426
27. Li Z.Q., Cheng T.O., Zhang W.W., et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. The Chinese experience in 119 patients from a single center. Int J Cardiol 93 (2004) 197-202
28. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy). J Am Coll Cardiol 42 (2003) 1687-1713
29. Maron B.J. Surgery for hypertrophic obstructive cardiomyopathy. Alive and quite well. Circulation 111 (2005) 2016-2018
30. Cheng T.O. Hypertrophic obstructive cardiomyopathy: alternative therapeutic options. Clin Cardiol 20 (1997) 667
31. Cheng T.O. Time for a prospective national or international registry. Catheter Cardiovasc Diagn 42 (1997) 234
32. Cheng T.O. Transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Circulation 100 (1999) 1252
33. Hui R.T. Contemporary diagnosis and treatment of hypertrophic cardiomyopathy. Chin J Cardiol 35 (2007) 82-85
34. Maron B.J. Hypertrophic cardiomyopathy. A systematic review. JAMA 287 (2002) 1308-1320